Survey Reveals 67% of Pharma Marketers See the Power of Predictive AI to Improve Targeting

Pharmaceutical and life sciences brands can proactively engage patients and providers using predictive AI to peer into the future and engage audiences based on what will likely happen in the moments that matter. 

But are healthcare marketers using this game-changing tool for proactive patient engagement?

A recent survey conducted by Swoop and MM+M, titled "Future-Proofing Strategies: Predictive AI in Marketing," reveals that while 67% of healthcare marketers are aware of AI's predictive capabilities, only 47.3% are actively seeking to implement this technology. As the healthcare industry navigates the complexities of AI adoption, concerns about privacy and security remain paramount. 

Swoop's innovative approach addresses these challenges head-on, offering privacy-safe, HIPAA-compliant predictive AI solutions that empower brands. By harnessing the power of zero-knowledge methodology and adhering to stringent regulations like Washington's My Health My Data (MHMD) Act, Swoop is paving the way for future-proof healthcare marketing strategies that optimize both health outcomes and commercial success.

For an in-depth look at the survey findings and expert insights on leveraging predictive AI in healthcare marketing, read the full report here.